This article has been updated from a previous version, which omitted the fact that Domain Associates also participated in the current funding round.
NEW YORK (GenomeWeb News) — GenVault today said it has secured $18 million in financing from Domain Associates and QuestMark Partners, a new investor.
As a result, Benjamin Schapiro, a partner at QuestMark, will join GenVault’s board of directors.
GenVault makes a dry-state platform that extracts, preserves, recovers, and distributes biosamples. GenVault said it plans to use the cash to help it commercialize the platform.
QuestMark focuses its investing on “late-stage growth companies in emerging markets,” GenVault said.